SEC Form D · filed August 14, 2023
UroGen Pharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Arie Belldegrun, M.D · Princeton, NJDirectorDan Wildman · Newton, MADirectorRan Nussbaum · Lexington, MADirectorStuart Holden, M.D · Princeton, NJDirectorJason A. Smith · Princeton, NJExecFred Cohen, M.D · Princeton, NJDirectorDon Kim · Princeton, NJExecJames A. Robinson, Jr · Princeton, NJDirectorCynthia Butitta · San Francisco, CADirectorElizabeth Barrett · Princeton, NJExec · DirectorLeana Wen, M.D., Msc · Princeton, NJDirectorMark A. Schoenberg, M.D · Princeton, NJExecStuart Holden, M.D · Princeton, NJDirectorJason A. Smith · Princeton, NJExecArie Belldegrun, M.D · Princeton, NJDirectorDan Wildman · Newton, MADirectorFred Cohen, M.D · Princeton, NJDirectorDon Kim · Princeton, NJExecJames A. Robinson, Jr · Princeton, NJDirectorCynthia Butitta · San Francisco, CADirectorRan Nussbaum · Los Angeles, CADirectorElizabeth Barrett · Princeton, NJExec · DirectorLeana Wen, M.D., Msc · Princeton, NJDirectorMark A. Schoenberg, M.D · Princeton, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗